Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 24/02/02

Trade details

Type
Insider sale
Amount
$35,783.35
Shares · price
4,195 sh · $8.53 a share
Held after
99,503 sh
Trade date
24/02/01
Filed
24/02/02
Days to filing
1 days

Sold 4.0% of holdings

Share of holding sold
4.0%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/02~24/03/02

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05